Aviragen (formerly Biota Pharmaceuticals Inc.) began a double-blind, placebo-controlled, U.K. Phase IIa
BTA585: Phase IIa started
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Aviragen (formerly Biota Pharmaceuticals Inc.) began a double-blind, placebo-controlled, U.K. Phase IIa